The field of interventional cardiology has made great strides in developing innovative treatments that have changed the lives of heart patients around the world. These are just some of the major advancements in which CRF played a role in the last two decades.
Transcatheter aortic valve replacement (TAVR) is a less invasive alternative to traditional valve replacement surgery. Instead of opening the chest, TAVR uses a catheter to replace a damaged heart valve through a small incision in the groin or the chest.
TAVR is currently approved for use in people with aortic stenosis who are at intermediate or high-risk for open heart surgery. Aortic stenosis is a narrowing of the aortic valve which limits blood flow in the heart.
Your gift goes to help save and improve the lives of people living with heart and vascular disease. Find out more or:
For naming opportunities or to support CRF’s mission contact email@example.com.